More Americans than ever support the legalization of cannabis in some form. In fact, a November 2019 poll from Pew Research found that a whopping 91% of adults believe that marijuana should be legal for medical and recreational use. With widespread support comes widespread acceptability, and with acceptability comes the desire to cash in.
Private financing and investing advice firm The Motley Fool says that the size of the marijuana industry is expected to triple in the next five years, and seasoned and novice investors alike are taking notice. However, investing in the cannabis industry is not exactly the same as investing in more mainstream — read “federally legal” — industries, like financials or utilities.
Investing in cannabis holds some unique challenges, like the legal risks of investing in an industry under federal prohibition, understanding imbalances in supply and demand, and how to mitigate the risks of investing in the decentralized and largely unregulated over-the-counter market, where the majority of marijuana stocks trade.
Fortunately, for investors looking to find their way, they can turn to Houston-based Alan Brochstein, CFA, Founder of subscription-based 420 Investor, and NCV Media, which fronts New Cannabis Ventures. He is also a leading blogger at Seeking Alpha, a crowd-sourced content service for financial markets.
Why Alan Brochstein?
Widely considered to be the leading cannabis industry financial and investment analyst, Brochstein has more than 20 years of experience as a portfolio manager and industry analyst. In 2007, Brochstein founded research firm AB Analytical Services, and in 2013, he pivoted to the cannabis industry. Spotting the need for more investor transparency, Brochstein launched 420 Investor, dedicated to providing objective and real-time information for cannabis investors.
However, you don’t have to subscribe to 420 Investor to gain cannabis industry investing insights. New Cannabis Ventures shares news, events and resources with the public for free on their site, while highlighting up-and-coming companies and leading investors. Investors are welcome to subscribe to NCV’s once-weekly newsletter, delivered each Sunday.
Brochstein has supported the legalization of marijuana since 1980 when he became an active member of the Libertarian Party, but it wasn’t until 2014 when he focused his analyst bona fides full time on the cannabis industry. Brochstein also puts his money where his mouth is by supporting cannabis advocacy and business groups like Students for Sensible Drug Policy, the Drug Policy Alliance, the National Cannabis Industry Association and Americans for Safe Access.
In a volatile industry replete with a lot of noise and unstable legal footing, Brochstein’s stated goals of helping investors find the “most promising public and private companies in the space while helping legitimate companies boost their exposure with potential investors, strategic partners, B2B customers, and the media,” sounds like just the advice a cannabis investor needs.
Featured image by Gina Coleman/Weedmaps
Erin Hiatt came to writing about cannabis, hemp, and psychedelics after a career as an actor and dancer. Her work has appeared in Vice, Civilized, MERRY JANE, Hemp Connoisseur Magazine, Marijuana Goes Mainstream, Doubleblind, and others.